<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9"><gtr:id>4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9</gtr:id><gtr:name>Geron Corporation</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9"><gtr:id>4C1744EE-64D0-4BAE-8BEA-2C4F1F8170A9</gtr:id><gtr:name>Geron Corporation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/13FD1EF0-BFFC-4E6A-871F-AB23CEA96DCE"><gtr:id>13FD1EF0-BFFC-4E6A-871F-AB23CEA96DCE</gtr:id><gtr:firstName>Herman</gtr:firstName><gtr:surname>Waldmann</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8D61EDAA-70A5-4AC4-A5FF-A8A3448C0FD0"><gtr:id>8D61EDAA-70A5-4AC4-A5FF-A8A3448C0FD0</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Jonathan</gtr:otherNames><gtr:surname>Fairchild</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0300230"><gtr:id>DE6F7F5D-C890-4247-A2CA-4329883E894B</gtr:id><gtr:title>Reprogramming the Immune System to Accept Histoincompatible Stem Cell-Derived Transplants.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0300230</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>313633</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Geron Corporation</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Geron corporation</gtr:description><gtr:id>663B451D-D8D8-4E32-844D-A488B582DF85</gtr:id><gtr:impact>yes-a joint paper with geron on GMP generation of dendritic cells from human ES cells Tseng, S. Y., K. P. Nishimoto, et al. (2009). &amp;quot;Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.&amp;quot; Regen Med 4(4): 513-26.</gtr:impact><gtr:partnerContribution>GMP serum free approach to generating dendritic cells from human ES cells</gtr:partnerContribution><gtr:piContribution>Patent and know how for deriving dendritic cells from human ES cells</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>dissemination</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>FF87B2A1-FA57-488C-9C12-F60AFC0E3EB5</gtr:id><gtr:impact>The co-applicant has had a number of opportunities to address lay audiences and interest groups concerning the importance of stem cell biology and to discuss some of the ethical and commercial implications. These include personal invitations to speak at the following organisations and events: - The Christian Medical Fellowship - The Said Business School, University of Oxford public event entitled 'Stem cell research in a nutshell'. - Venturefest 2007: An annual event, open to the public, aimed at engaging commercial interest and venture capital for the commercialisation of new technologies

Our ongoing programme of research has attracted widespread interest in the media and scientific literature. News articles that directly discuss our research and its implications include the following: - Framework bolsters stem cell progress. (2004) Curr Biol 14:R592-593 - New cells for old? (2004) Oxford Today 17:29-31 - Die Insel der Stammzellforscher. (2004) Nachr Chem 52:1261-1264 - Mit stammzellen heilen, ohne viele Embryonen zu verbrauchen. Die Welt 2 Aug 2005 p31 - Pushing stem cells to market. (2005) Curr Biol 15:R576-R577 - Cloning: What now? (2006) Nature 439:652-657 - Stem cell selling. (2006) Curr Biol 16:R818-R819 Our research has also been featured in Biological Science Reviews, a journal that caters primarily for the needs of 'A' level students. As a consequence, the co-applicant has received numerous invitations to lead workshops for 'A' level and GCSE students in local schools, outreach activities which are still ongoing. In all such communications with the public, the support of the MRC has been gratefully acknowledged.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Dendritic cells from ES cells</gtr:description><gtr:id>21E9429E-A1DE-4B31-BE40-A1FE5586C4CB</gtr:id><gtr:impact>a way to avoid rejection of stem cell derived tissues</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>US7247480</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>method of producing dendritic cells</gtr:title><gtr:yearProtectionGranted>2007</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>production of dendritic cells from embryonic stem cells</gtr:description><gtr:id>42B6C4F2-B74F-4D40-A010-E9F9DD618E0A</gtr:id><gtr:impact>possibe universal approach to stopping rjection of ES derived tissues</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>US2011014696</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Method for producing dendritic cells</gtr:title><gtr:yearProtectionGranted>2011</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Es cell lines from different strains of mcie-a generally useful tool for stem cell research</gtr:description><gtr:id>0D154562-07E5-4F62-ADC1-9CE1EF8AAF1E</gtr:id><gtr:impact>Identification of some level of immune protection of tissues derived from ES cells</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>novel ES cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AA1DEC3-D59F-4416-B733-70EC187634B2"><gtr:id>0AA1DEC3-D59F-4416-B733-70EC187634B2</gtr:id><gtr:title>Immune privilege induced by regulatory T cells in transplantation tolerance.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ffceb12522ddfcc1b45e3dd4aa6349eb"><gtr:id>ffceb12522ddfcc1b45e3dd4aa6349eb</gtr:id><gtr:otherNames>Cobbold SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23C95B15-1F8D-4BA5-BB3D-7759EE0284B4"><gtr:id>23C95B15-1F8D-4BA5-BB3D-7759EE0284B4</gtr:id><gtr:title>Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b826733a753cd241606247afc5487101"><gtr:id>b826733a753cd241606247afc5487101</gtr:id><gtr:otherNames>Tseng SY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC37651E-FF68-4078-9614-FE9944D2524A"><gtr:id>BC37651E-FF68-4078-9614-FE9944D2524A</gtr:id><gtr:title>Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aad47ac13f2362b1f5cf818ca4c17946"><gtr:id>aad47ac13f2362b1f5cf818ca4c17946</gtr:id><gtr:otherNames>Yates SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52CE5090-9B13-4AA7-8BA9-18D2D3A97E92"><gtr:id>52CE5090-9B13-4AA7-8BA9-18D2D3A97E92</gtr:id><gtr:title>Embryonic stem cells: protecting pluripotency from alloreactivity.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E02003A1-98F7-47E1-A284-EAAC713D81D9"><gtr:id>E02003A1-98F7-47E1-A284-EAAC713D81D9</gtr:id><gtr:title>Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7c9ee0469e4235765d6d620108426297"><gtr:id>7c9ee0469e4235765d6d620108426297</gtr:id><gtr:otherNames>Robertson NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/310AAE7C-56CF-45F3-911E-C83E25C362AD"><gtr:id>310AAE7C-56CF-45F3-911E-C83E25C362AD</gtr:id><gtr:title>A role for regulatory T cells in acceptance of ESC-derived tissues transplanted across an major histocompatibility complex barrier.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/760d02a5d76154f04677d338e441b556"><gtr:id>760d02a5d76154f04677d338e441b556</gtr:id><gtr:otherNames>Lui KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26F45927-BA3F-4756-9EEA-33A8B28E7B5F"><gtr:id>26F45927-BA3F-4756-9EEA-33A8B28E7B5F</gtr:id><gtr:title>Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy.</gtr:title><gtr:parentPublicationTitle>Current stem cell research &amp; therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/760d02a5d76154f04677d338e441b556"><gtr:id>760d02a5d76154f04677d338e441b556</gtr:id><gtr:otherNames>Lui KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1574-888X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/144DE650-9CB5-4F39-9952-A6248036AED8"><gtr:id>144DE650-9CB5-4F39-9952-A6248036AED8</gtr:id><gtr:title>Cell replacement therapy and the evasion of destructive immunity.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9aabd38d22ef90645151cece851cdb1b"><gtr:id>9aabd38d22ef90645151cece851cdb1b</gtr:id><gtr:otherNames>Fairchild PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0300230</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>